Lviv Regional Clinical Hospital; Department of Neurology

Lviv 79010

0 studies enrolling now · 2 studies all time

What they study most

Multiple Sclerosis, Primary Progressive, Relapsing Multiple Sclerosis

Studies at this site

• A Study of Ocrelizumab in Comparison With Interferon Beta-1a (Rebif) in Participants With Relapsing Multiple Sclerosis — Completed
• A Study of Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis — Completed